ArticleOncology and therapy2026

Exploratory Analyses of Patient Preferences for Atezolizumab Subcutaneous Versus Intravenous from the IMscin002 Study in Patients with Non-Small Cell Lung Cancer.

Margarita Majem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.